Dr Richard Kaszynski on the importance of antivirals - European Medical Journal

Dr Richard Kaszynski on the importance of antivirals

EMJ GOLD
Season 01: Episode 74

This week, GOLD talks to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN programme, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.

A little more on GOLD’s guest…

Dr Richard Kaszynski is the Chief Medical Officer at AiPharma, and the co-founder of GUARDIAN, developed in collaboration with Imperial College London. He was previously the Senior Medical Advisor to the Democratic Republic of Congo, where he worked with the coordinator general of the Ebola response to combat and contain the Ebola outbreak. He also acted as the lead clinician on the anti-infectious disease team at the Tokyo Olympics earlier this year.

Topics covered

  • Time taken for FDA approvals
  • Drug repurposing
  • Improving safety at mass gatherings
  • Preventative medicine

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>